Claims for Patent: 8,623,591

Summary for Patent: 8,623,591

Title:	Method for separating desired cells from tissue by freezing
Abstract:	Methods of isolating cellular products, such as pancreatic islets, may be used in diabetes research and therapeutic transplantation. The methods may involve providing a tissue having desired cells that are less prone to destructive freezing and undesired cells that are more prone to destructive freezing, or pre-treating a tissue to have such characteristics. The methods may involve freezing the tissue, disrupting the tissue, warming the tissue, and separating the desired cells from undesired cellular material to obtain the cellular product. The methods may thereby provide an enzyme-free or reduced-enzyme method of isolating a cellular product that is more consistent, reliable and less toxic than conventional methods. The methods may also yield an optimum quantity of cellular product that retain sufficient functional integrity to be useful as a transplantation resource.
Inventor(s):	Taylor; Michael J. (Mount Pleasant, SC), Pegg; David E. (York, GB)
Assignee:	Lifeline Scientific, Inc. (Itasca, IL)
Application Number:	13/595,536
Patent Claims:	1. A method, comprising: providing a tissue having desired cells that are less prone to destructive freezing and undesired cells that are more prone to destructive freezing, infusing the desired cells with a cryoprotectant solution comprising a cryoprotective agent, and infusing the undesired cells with solution that does not contain the cryoprotective agent; freezing the tissue; disrupting the tissue; warming the tissue; and separating the desired cells from undesired cellular material to obtain a product. 2. The method of claim 1, wherein the tissue is pancreatic tissue and the product is pancreatic islets. 3. The method of claim 2, further comprising treating the pancreatic islets with a digestive enzyme. 4. The method of claim 2, wherein freezing the pancreatic tissue comprises freezing the pancreas to a temperature of from about -10.degree. C. to about -200.degree. C. 5. The method of claim 2, wherein freezing the pancreatic tissue occurs at a cooling rate of from about 1.degree. C./min. to about 20.degree. C./min. 6. The method of claim 2, wherein warming the pancreatic tissue occurs at a warming rate of more than about 12.degree. C./min. 7. The method of claim 2, wherein warming the pancreatic tissue is achieved by direct immersion of the tissue in a warm osmotically-buffered medium. 8. The method of claim 2, wherein disrupting the pancreatic tissue is achieved by a technique selected from the group consisting of mechanical stress, thermo-mechanical stress induced by differential expansion, thermo-mechanical stress induced by steep temperature gradients, and thermo-mechanical stress induced by volume change upon freezing, and combinations thereof. 9. The method of claim 2, wherein disrupting the pancreatic tissue is achieved while the pancreatic tissue is frozen or while the pancreatic tissue is thawing. 10. The method of claim 2, further comprising adding a collagenase to the pancreatic tissue at a concentration of less than 1.4 mg/ml. 11. The method of claim 2, wherein the pancreatic islets are infused with the cryoprotectant solution via a vascular system, and acinar tissue is infused with with the solution that does not contain the cryoprotective agent via a ductal system. 12. The method of claim 11, wherein the cryoprotective agent is selected from the group consisting of dimethyl sulfoxide, glycerol, ethylene glycol, propylene glycol, sucrose and trehalose. 13. The method of claim 11, wherein the aqueous solution is water or isotonic saline. 14. The method of claim 11, wherein infusing the pancreatic islets with the cryoprotectant solution is performed at a temperature of from about 2.degree. C. to about 35.degree. C. and for a period of about 20 to about 70 minutes. 15. The method of claim 11, wherein infusing the acinar tissue with an aqueous solution is continued until the pancreatic tissue is visibly distended. 16. The method of claim 11, wherein the cryoprotective agent is present in the cryoprotectant solution at a concentration of from about 0.5 molar to about 3.0 molar. 17. The method of claim 11, further comprising eluting the cryoprotective agent from the pancreatic islets and applying osmotic buffering to the pancreatic tissue during the elution of the cryoprotective agent from the pancreatic islets. 18. The method of claim 1, wherein infusing the desired cells with a cryoprotectant solution comprises pre-treating the tissue with the cryoprotectant solution until the desired cells equilibrate thermodynamically with the cryoprotective agent.

Details for Patent 8,623,591

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2028-12-12